Exazyme
Exazyme helps biotech and pharmaceutical teams discover higher-performing proteins with far fewer experiments. The company offers an AI-driven protein design platform that combines models and methods such as ProtBert, ESM, UniRep, Gaussian processes, Bayesian optimization, cryo-EM–aware bioinformatics and Python-based tooling to predict beneficial sequence changes. The platform can be deployed on-site or accessed via API and is sold as a project-based, one-off flat-rate engagement. Exazyme targets biotech, pharma, and industrial biotech innovators seeking to accelerate enzyme and therapeutic protein engineering at scale.
Exazyme
Exazyme helps biotech and pharmaceutical teams discover higher-performing proteins with far fewer experiments. The company offers an AI-driven protein design platform that combines models and methods such as ProtBert, ESM, UniRep, Gaussian processes, Bayesian optimization, cryo-EM–aware bioinformatics and Python-based tooling to predict beneficial sequence changes. The platform can be deployed on-site or accessed via API and is sold as a project-based, one-off flat-rate engagement. Exazyme targets biotech, pharma, and industrial biotech innovators seeking to accelerate enzyme and therapeutic protein engineering at scale.